REFILE-UPDATE 2-Citron turns spotlight on Mallinckrodt, shares plunge

Nov 9 (Reuters) - Shares of Mallinckrodt Plc closed down 17 percent after short-seller Citron Research called the drugmaker "a far worse offender of the reimbursement system" in a tweet.